These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 19274589

  • 1. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.
    Abd El-Sattar Fahmy S, Christensen JM, Ayres JW.
    Drug Dev Ind Pharm; 2009 Aug; 35(8):1009-21. PubMed ID: 19274589
    [Abstract] [Full Text] [Related]

  • 2. Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery.
    Li DX, Kim JO, Oh DH, Lee WS, Hong MJ, Kang JY, Choi JS, Woo JS, Yong CS, Choi HG.
    Arch Pharm Res; 2009 Jan; 32(1):127-32. PubMed ID: 19183885
    [Abstract] [Full Text] [Related]

  • 3. An in vitro-in vivo correlation study for nifedipine immediate release capsules administered with water, alcoholic and non-alcoholic beverages: Impact of in vitro dissolution media and hydrodynamics.
    Mercuri A, Fares R, Bresciani M, Fotaki N.
    Int J Pharm; 2016 Feb 29; 499(1-2):330-342. PubMed ID: 26721731
    [Abstract] [Full Text] [Related]

  • 4. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M, Abe K, Hashizume M, Kawamura M.
    Int J Pharm; 2008 Jul 09; 359(1-2):46-52. PubMed ID: 18467046
    [Abstract] [Full Text] [Related]

  • 5. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y, Zhao F, Paborji M.
    Pharm Dev Technol; 2003 Jul 09; 8(4):379-83. PubMed ID: 14601962
    [Abstract] [Full Text] [Related]

  • 6. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
    Barbosa JAC, Al-Kauraishi MM, Smith AM, Conway BR, Merchant HA.
    Eur J Pharm Biopharm; 2019 Nov 09; 144():174-179. PubMed ID: 31541663
    [Abstract] [Full Text] [Related]

  • 7. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL, Lin SY, Lin YK, Ho HO, Lo YW, Sheu MT.
    Eur J Pharm Biopharm; 2008 Sep 09; 70(1):289-301. PubMed ID: 18539015
    [Abstract] [Full Text] [Related]

  • 8. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps.
    Prabakaran D, Singh P, Kanaujia P, Vyas SP.
    Int J Pharm; 2003 Jun 18; 259(1-2):173-9. PubMed ID: 12787645
    [Abstract] [Full Text] [Related]

  • 9. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H, Qing D, De-Ying C, Bai X, Fanli-Fang.
    PDA J Pharm Sci Technol; 2007 Jun 18; 61(2):121-30. PubMed ID: 17479720
    [Abstract] [Full Text] [Related]

  • 10. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M, Newton M, Booth S, Clarke A.
    Eur J Pharm Biopharm; 2007 Jan 18; 65(1):94-8. PubMed ID: 17056237
    [Abstract] [Full Text] [Related]

  • 11. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F, Jones BE.
    Drug Dev Ind Pharm; 2002 Oct 18; 28(9):1163-9. PubMed ID: 12455475
    [Abstract] [Full Text] [Related]

  • 12. Factors affecting the release of nifedipine from a swellable elementary osmotic pump.
    Nokhodchi A, Momin MN, Shokri J, Shahsavari M, Rashidi PA.
    Drug Deliv; 2008 Jan 18; 15(1):43-8. PubMed ID: 18197523
    [Abstract] [Full Text] [Related]

  • 13. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation.
    Yehia SA, Elshafeey AH, Elsayed I.
    Drug Deliv; 2011 Nov 18; 18(8):620-30. PubMed ID: 22111975
    [Abstract] [Full Text] [Related]

  • 14. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
    Chowdary KP, Kamalakara RG.
    Pharmazie; 2003 Oct 18; 58(10):721-4. PubMed ID: 14609284
    [Abstract] [Full Text] [Related]

  • 15. Photostability of extended-release matrix formulations.
    Maggi L, Ochoa Machiste E, Fasani E, Albini A, Segale L, Conte U.
    Eur J Pharm Biopharm; 2003 Jan 18; 55(1):99-105. PubMed ID: 12551710
    [Abstract] [Full Text] [Related]

  • 16. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y, Sun Y, Sun J, Zhao N, Sun M, He Z.
    Int J Pharm; 2012 Apr 15; 426(1-2):21-28. PubMed ID: 22266529
    [Abstract] [Full Text] [Related]

  • 17. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
    Vardakou M, Mercuri A, Naylor TA, Rizzo D, Butler JM, Connolly PC, Wickham MS, Faulks RM.
    Int J Pharm; 2011 Oct 31; 419(1-2):192-9. PubMed ID: 21843611
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and characterization of osmotic pump capsules containing polyoxyethylene and pH modifier to control the release of nifedipine.
    Yu J, Meng X, Dong X, Han M, Li G, Chen Y, Liu Y, Hu L.
    Eur J Pharm Biopharm; 2021 Jun 31; 163():102-108. PubMed ID: 33819628
    [Abstract] [Full Text] [Related]

  • 19. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM, Sankalia MG, Mashru RC.
    J Control Release; 2008 Jul 02; 129(1):49-58. PubMed ID: 18456362
    [Abstract] [Full Text] [Related]

  • 20. Development and in-vitro evaluation of a colon-specific controlled release drug delivery system.
    Talukder RM, Fassihi R.
    J Pharm Pharmacol; 2008 Oct 02; 60(10):1297-303. PubMed ID: 18812022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.